Stocks of the Hour: Vintage Energy, Rumble Resources, QX Resources, Dimerix, BluGlass
Stocks of the Hour: Vintage Energy, Rumble Resources, QX Resources, Dimerix, BluGlass
Vintage Energy (ASX:VEN) announces an additional two-year gas sale under the master gas supply agreement for the Odin gas field. The joint venture parties have agreed and signed terms with Pelican Point Power for the supply of gas from 1 January 2025 to 31 December 2026. Shares are trading flat at 2.7 cents.
Vintage Energy（澳大利亚证券交易所股票代码：VEN）宣布，根据奥丁气田的主天然气供应协议，再出售两年的天然气。合资双方已与Pelican Point Power就2025年1月1日至2026年12月31日的天然气供应达成协议并签署了条款。股价持平至2.7美分。
Rumble Resources (ASX:RTR) has announced that high grade zinc and lead has been intersected at the Earaheedy Project. The width and tenor of mineralisation intercepted indicates that potential feeder faults exist at the Project and confirms the prospectivity of the 9km x 3km area to host high grade Zn-Pb sulphide mineralisation. Shares are trading 4.76 per cent higher at 11 cents.
Rumble Resources（澳大利亚证券交易所股票代码：RTR）宣布，Earaheedy Project已将高品位的锌和铅相交。截获的矿化宽度和宽度表明，该项目存在潜在的支线断层，并证实了9km x 3km区域拥有高品位Zn-Pb硫化物矿化的前景。股价上涨4.76％，至11美分。
QX Resources (ASX:QXR) has signed a formal documentation to acquire a 75% Interest in the 100km2 Liberty Lithium Brine Project in the USA. In response, QXR Managing Director, Stephen Promnitz, said: "The Liberty Lithium Project is potentially a new large-scale lithium brine project - in the right location, with good infrastructure and a pathway to development." Shares are on a trading halt and last traded at 2.3 cents.
QX Resources（澳大利亚证券交易所股票代码：QXR）已签署一份正式文件，收购美国100平方公里的Liberty锂盐水项目75％的权益。作为回应，QXR董事总经理Stephen Promnitz表示：“Liberty Lithium Promnitz可能是一个新的大型锂盐水项目——位于正确的地点，拥有良好的基础设施和发展途径。”股票暂停交易，最后一次交易价格为2.3美分。
Dimerix (ASX:DXB) and ADVANZ PHARMA have entered into an exclusive licence agreement for the UK, Switzerland, Canada, Australia, and New Zealand for the commercialisation of Dimerix' Phase 3 drug candidate DMX-200 for the treatment of FSGS, which is a rare type of kidney disease. Dimerix will receive up to ~AU$230* million in upfront and milestone payments, plus royalties. Shares are trading 88.52 per cent higher at 11.5 cents.
Dimerix（澳大利亚证券交易所股票代码：DXB）和ADVANZ PHARMA已与英国、瑞士、加拿大、澳大利亚和新西兰签订了独家许可协议，用于治疗FSGS（一种罕见的肾脏疾病）的Dimerix的3期候选药物 DMX-200 的商业化。Dimerix将获得高达2.3亿澳元*的预付款和里程碑付款，外加特许权使用费。股价上涨88.52％，至11.5美分。
BluGlass Limited (ASX:BLG) has been named a member of the Commercial Leap Ahead for Wide-bandgap Semiconductors (CLAWS) Hub, one of eight Microelectronics Commons regional innovation hubs announced by the US Department of Defense. This is a part of the US$238M funding initiative in FY23 to establish these hubs, aimed at boosting America's capabilities in cutting-edge microelectronics development and production. Shares are trading 13.51 per cent higher at 4.2 cents.
BluGlass Limited（澳大利亚证券交易所股票代码：BLG）被任命为宽带隙半导体商业飞跃（CLAWS）中心的成员，该中心是美国国防部宣布的八个微电子共享区域创新中心之一。这是2023财年2.38亿美元资金计划的一部分，旨在建立这些中心，旨在提高美国在尖端微电子开发和生产方面的能力。股价上涨13.51％，至4.2美分。
译文内容由第三方软件翻译。